Evidence map›Paper›PMID 41055395›Full record

ArticleMicrobiology spectrum2025

Epidemiological and genomic characteristics of

Fangyuan Cui, Haiying Qian, Xuefeng Miao, Dengying Jia, Shengnan Liang, Lihong Cheng, Hui Yuan, Lijun Huan

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Nosocomial outbreak ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fangyuan CuiLiaocheng Center for Disease Control and Prevention, Liaocheng, Shandong, China.ORCID 0000-0002-6634-8697
Haiying QianDepartment of Laboratory, Liaocheng Third People's Hospital, Liaocheng, Shandong, China.
Xuefeng MiaoLiaocheng Center for Disease Control and Prevention, Liaocheng, Shandong, China.
Dengying JiaDepartment of Pharmaceutical Inspection, Liaocheng Inspection and Testing Center, Liaocheng, Shandong, China.
Shengnan LiangLiaocheng Center for Disease Control and Prevention, Liaocheng, Shandong, China.
Lihong ChengLiaocheng Center for Disease Control and Prevention, Liaocheng, Shandong, China.
Hui YuanLiaocheng Center for Disease Control and Prevention, Liaocheng, Shandong, China.
Lijun HuanLiaocheng Center for Disease Control and Prevention, Liaocheng, Shandong, China.ORCID 0009-0002-1454-9603

Funding

Shandong Medical and Health Science and Technology Development Program 202212061076
6 · The paper itself

Abstract

IMPORTANCE:

Indexed as

BacteremiaGram-Negative Bacterial InfectionsRalstoniaAdultAgedAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesChinaCross InfectionDrug Resistance, Multiple, BacterialFemaleGenome, BacterialHumansMaleMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescgMLSTcomparative analysismultidrug-resistancenosocomial outbreaksRalstonia mannitolilytica

Identifiers

PMID41055395
PMCPMC12584647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.